Understanding the Future of Hemophilia B Care
Hosted by Dr. David Clark, Live-Streamed in the B-Hub
August 19th: Cell and Gene Therapy
Innovation Lab
Understanding the Future of Hemophilia B Care
Sponsored by Pfizer
Hosted by Dr. David Clark
The pace of innovation in hemophilia B has never been greater. From extended half-life therapies and rebalancing agents to gene therapy and emerging treatments still on the horizon, individuals and families are navigating more options than ever before.
Join Dr. David Clark for an eight-week educational series designed to help participants better understand the evolution of hemophilia B treatment and the innovations shaping the future of care. Together, we'll explore how treatment has progressed over time, examine current therapeutic approaches, discuss the benefits and considerations of different options, and take a closer look at the research and advancements that may influence care in the years ahead.
Whether you are newly diagnosed, evaluating treatment options, supporting a loved one, or simply curious about where the field is headed, Innovation Lab offers an opportunity to learn, ask questions, and build confidence in understanding the rapidly changing treatment landscape.
Each session will feature a live presentation followed by opportunities for questions and discussion.
Access the learning lab lessons and resources here!
Livestream Schedule
July 8: History of Hemophilia B Treatment
July 15: Extended Half-Life Products
July 22: Understanding Inhibitor Treatment
July 29: Rebalancing Agents
August 5: A Closer Look at Hympavzi
August 19: Cell & Gene Therapy
August 26: Future Treatment Innovations
September 2: Treatment Considerations for Women